跳至主要内容
临床试验/NCT04061122
NCT04061122Unknown不适用

The Role of Congenital Mucosal Immune System in the Airways of Patients With COPD

Medical University of Lodz1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年7月4日最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
percentage of nasal ILCs (Innate lymphoid cells) after COPD exacerbation

研究概览

简要总结

The purpose of the study is to explore the role of congenital mucosal immune system in the airways of patients with COPD including the impact of ILCs (Innate lymphoid cells) on metabolism of epithelial cells.During the research the following methods will be applied: measurement of Volatile Organic Compounds (VOCS), airway epithelial cytology and culture.

详细描述

ILCs profiles, epithelium metabolism measured by VOCS and microbiome profiling (specific 16S rRNA-16S ribosomal RNA gene-targeted qPCR) will by determined in the airways of patients with COPD after the exacerbation. Microbiome profiling will be based on next generation sequencing (NGS) of the 16S rRNA encoding region.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • acute airway infection in last 2 weeks

结局指标

主要结局

percentage of nasal ILCs (Innate lymphoid cells) after COPD exacerbation

时间窗: through study completion, an average of 1 year

The assessment of the nasal mucosa material after COPD exacerbation will include: percentage of ILC1, 2 and 3 cells (immunophenotyping and measurement by flow cytometry)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pawel Majak

Principal Investigator

Medical University of Lodz

研究点 (1)

Loading locations...

相似试验